Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 8/20 | 0.37 |
| ▸ | CNR2 | P34972 | 5/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20104976 | 0.86 | ACACB (0.38) | ACACBCNR1CNR2SLC6A2SLC6A4 | |
| SCHEMBL21709878 | 0.85 | CYP2C9 (0.40) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL19954387 | 0.85 | CNR1 (0.35) | CNR1CNR2POLBPKMMEN1 | |
| SCHEMBL14228173 | 0.84 | ACACB (0.40) | ACACBCNR1CNR2SLC6A2SLC6A4 | |
| SCHEMBL18412109 | 0.81 | ACACB (0.41) | ACACBCNR1CNR2SLC6A2SLC6A4 | |
| SCHEMBL18412091 | 0.79 | ACACB (0.44) | ACACBCNR1CNR2SLC6A2SLC6A4 | |
| SCHEMBL13473083 | 0.79 | MDH1 (0.31) | CNR1CNR2 | |
| SCHEMBL21701076 | 0.77 | NPSR1 (0.37) | SLC6A2SLC6A4SLC6A3POLBPKM | |
| SCHEMBL20987300 | 0.77 | ELANE (0.56) | ACACBCNR1CNR2MEN1KMT2A | |
| SCHEMBL13283534 | 0.76 | ACACB (0.38) | ACACBCNR1CNR2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11366386-B2 | Patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-06-21 | — | — | US | disclosed |
| US-20190354017-A1 | PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-11-21 | — | — | US | disclosed |
| EP-1764652-B1 | Positive resist composition and pattern-forming method using the same | FUJIFILM CORP (JP) | 2014-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11366386-B2 | Patterning process | FEM1B, EGLN1, TET1 | ACACB 287/4885CNR1 2488/4885CNR2 2696/4885 |
| US-20190354017-A1 | PATTERNING PROCESS | FEM1B, EGLN1, TET1 | ACACB 287/4885CNR1 2488/4885CNR2 2696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.